Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Power Medical Interventions (PMI) was a medical technology company that pioneered the development of computer-assisted, power-actuated surgical stapling systems. The company's "Intelligent Surgical Instruments" platform, featuring the iDrive and iReach devices, utilized microprocessor-controlled technology to provide surgeons with enhanced precision and control during minimally invasive procedures. These systems were designed to improve staple line security and tissue management in complex surgeries, including gastrointestinal, thoracic, and bariatric operations. In 2009, PMI was acquired by Covidien for approximately $64 million, and its innovative digital stapling technology was subsequently integrated into the surgical portfolios of Covidien and later Medtronic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PowerMedical Interventions.